✦ LIBER ✦

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

✍ Scribed by Palumbo, A.; Cavo, M.; Bringhen, S.; Zamagni, E.; Romano, A.; Patriarca, F.; Rossi, D.; Gentilini, F.; Crippa, C.; Galli, M.; Nozzoli, C.; Ria, R.; Marasca, R.; Montefusco, V.; Baldini, L.; Elice, F.; Callea, V.; Pulini, S.; Carella, A. M.; Zambello, R.; Benevolo, G.; Magarotto, V.; Tacchetti, P.; Pescosta, N.; Cellini, C.; Polloni, C.; Evangelista, A.; Caravita, T.; Morabito, F.; Offidani, M.; Tosi, P.; Boccadoro, M.

Book ID: 126837551
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 149 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2010.31.6844

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enoxaparin or aspirin for the prevention

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

✍ A. PALUMBO; C. RUS; J. B. ZELDIS; F. RODEGHIERO; M. BOCCADORO; THE ITALIAN MULTI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

A Phase III Randomized, Open-Label, Cont

A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer

✍ Zev Wainberg; J. Randolph Hecht 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

An open-label, single-arm, phase 2 study

An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

4003 ICE Study: A prospective, multi-cen

4003 ICE Study: A prospective, multi-centre, controlled, open-label, randomized phase III trial of ibandronate (I) with or without capecitabine (X) in elderly patients (pts) with early breast cancer (GBG 32)

✍ T. Reimer; U. Nitz; J. Potenberg; B. Conrad; H. Graf; M. Just; H. Eidtmann; S. L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB